Antiviral Peptide + Nonhormonal Contraceptive IVR
- User: Female
- Hormonal: Non-Hormonal
-
Delivery type:
- Vaginal Ring
-
Intended Duration:
- Not Yet Determined
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): Oak Crest Institute of Science
Details
- API: Not Yet Finalized - sAC Inhibitor + Antiviral Peptide
- Target: Multiple - sAC + viral targets
-
Mechanism of Action:
- Anti-Microbial
- Inhibition of Sperm Motility
- Inactive Materials: Not Yet Determined
- Regimen: Not Yet Determined
- MPT: Potential MPT
- Promising Attributes: The method would offer both protection from unintended pregnancy and from viral infection, without hormones and without the need to use immediately before/after sex.
Product Status
Active or Recent Pre-Clinical Development
History
2024: Oak Crest awarded NIH funds to support the development of an MPT IVR intended to primarily protect against HSV, in addition to preventing unintended pregnancy.